Farallon Capital Management LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Farallon Capital Management LLC

  • $17.4 Billion
  • Q1 2025

A detailed history of Farallon Capital Management LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Farallon Capital Management LLC holds 15,800 shares of ARWR stock, worth $248,692. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,800
Holding current value
$248,692
% of portfolio
0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$12.74 - $21.53 $7.81 Million - $13.2 Million
-613,000 Reduced 97.49%
15,800 $201,000
Q4 2024

Feb 14, 2025
BUY
$17.7 - $26.34 $11.1 Million - $16.6 Million
628,800 New
628,800 $11.8 Million
Q2 2023

Aug 14, 2023
BUY
$25.16 - $41.38 $145,928 - $240,004
5,800 New
5,800 $206,000
Q1 2022

May 16, 2022
SELL
$39.62 - $69.97 $7.05 Million - $12.4 Million
-177,917 Reduced 55.49%
142,700 $6.56 Million
Q4 2021

Feb 14, 2022
SELL
$58.09 - $82.51 $27.6 Million - $39.3 Million
-475,961 Reduced 59.75%
320,617 $21.3 Million
Q3 2021

Nov 15, 2021
BUY
$58.38 - $84.96 $25.2 Million - $36.7 Million
431,578 Added 118.24%
796,578 $49.7 Million
Q2 2021

Aug 13, 2021
BUY
$62.15 - $90.32 $12 Million - $17.4 Million
192,546 Added 111.65%
365,000 $30.2 Million
Q1 2021

May 17, 2021
BUY
$61.35 - $90.47 $6.43 Million - $9.49 Million
104,854 Added 155.11%
172,454 $11.4 Million
Q4 2020

Feb 16, 2021
SELL
$43.82 - $85.37 $15.6 Million - $30.4 Million
-356,000 Reduced 84.04%
67,600 $5.19 Million
Q3 2020

Nov 16, 2020
SELL
$33.21 - $51.27 $12.5 Million - $19.3 Million
-376,400 Reduced 47.05%
423,600 $18.2 Million
Q2 2020

Aug 14, 2020
SELL
$26.12 - $43.27 $5.22 Million - $8.65 Million
-200,000 Reduced 20.0%
800,000 $34.6 Million
Q1 2020

May 15, 2020
BUY
$20.56 - $63.12 $18.5 Million - $56.8 Million
900,000 Added 900.0%
1,000,000 $28.8 Million
Q4 2019

Feb 13, 2020
SELL
$28.14 - $73.01 $15.5 Million - $40.2 Million
-550,000 Reduced 84.62%
100,000 $6.34 Million
Q3 2019

Nov 14, 2019
SELL
$26.26 - $34.86 $35.5 Million - $47.1 Million
-1,350,000 Reduced 67.5%
650,000 $18.3 Million
Q2 2019

Aug 14, 2019
BUY
$17.43 - $28.82 $1.38 Million - $2.29 Million
79,391 Added 4.13%
2,000,000 $53 Million
Q1 2019

May 15, 2019
BUY
$12.05 - $20.18 $5.07 Million - $8.49 Million
420,609 Added 28.04%
1,920,609 $35.2 Million
Q4 2018

Feb 14, 2019
BUY
$10.74 - $19.7 $16.1 Million - $29.6 Million
1,500,000 New
1,500,000 $18.6 Million

Others Institutions Holding ARWR

# of Institutions
300
Shares Held
98M
Call Options Held
306K
Put Options Held
432K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $1.67B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Farallon Capital Management LLC Portfolio

Follow Farallon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email